23andMe Thinks Polygenic Risk Scores Are Ready for the Masses, But Experts Aren’t So Sure

A new genetic test that estimates your risk for diabetes is probably less useful than standing on a scale

Photo sources: Sharon McCutcheon/Unsplash; 23andMe

By Antonio Regalado

23andMe, the direct-to-consumer DNA testing company in Silicon Valley whose motto is…

This story is just a click away.

Sign up for a free Medium account to read this story from MIT Technology Review. Plus, get one more story in your member preview this month.

Already have an account? Sign in

This story is just a click away.

Sign up for a free Medium account to read this story from MIT Technology Review. Plus, get one more story in your member preview this month.
Already have an account? Sign in